CO stock up over 20% as investors seek meeting to oppose Cellenkos acquisition (NYSE:CO)
Global Cord Blood Corporation (CO) added over 20% Friday on the news that investors holding 75% of the company’s outstanding shares have requested an Extraordinary General Meeting…
CO stock up over 20% as investors seek meeting to oppose Cellenkos acquisition (NYSE:CO)
Global Cord Blood Corporation (CO) added over 20% Friday on the news that investors holding 75% of the company’s outstanding shares have requested an Extraordinary General Meeting…